The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and legal actions taken by regulatory authorities around the world. It also provides signals based on information derived from the WHO global database of individual case safety reports, VigiBase.
In addition, this edition of the Newsletter includes an article on the Global Vaccine Safety Blueprint 2.0 (GVSB 2.0).